ADJUVANT CHEMOTHERAPY AND ENDOCRINE THERAPY FOR NODE-POSITIVE AND NODE-NEGATIVE BREAST-CARCINOMA

被引:3
作者
ALBAIN, KS
机构
关键词
D O I
10.1097/00003081-198912000-00026
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
引用
收藏
页码:835 / 857
页数:23
相关论文
共 62 条
[1]   THE RELATION BETWEEN SURVIVAL AND AGE AT DIAGNOSIS IN BREAST-CANCER [J].
ADAMI, HO ;
MALKER, B ;
HOLMBERG, L ;
PERSSON, I ;
STONE, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (09) :559-563
[2]  
BAUM M, 1988, BRIT J CANCER, V57, P608
[3]  
BLOT WJ, 1987, J NATL CANCER I, V78, P451
[4]  
BONADONNA G, 1987, SEMIN ONCOL, V14, P8
[5]   10-YEAR EXPERIENCE WITH CMF-BASED ADJUVANT CHEMOTHERAPY IN RESECTABLE BREAST-CANCER [J].
BONADONNA, G ;
VALAGUSSA, P ;
ROSSI, A ;
TANCINI, G ;
BRAMBILLA, C ;
ZAMBETTI, M ;
VERONESI, U .
BREAST CANCER RESEARCH AND TREATMENT, 1985, 5 (02) :95-115
[6]  
BONADONNA G, 1987, ADJUVANT THERAPY CAN, V5, P211
[7]   EVIDENCE OF A CASTRATION-MEDIATED EFFECT OF ADJUVANT CYTOTOXIC CHEMOTHERAPY IN PREMENOPAUSAL BREAST-CANCER [J].
BRINCKER, H ;
ROSE, C ;
RANK, F ;
MOURIDSEN, HT ;
JAKOBSEN, A ;
DOMBERNOWSKY, P ;
PANDURO, J ;
ANDERSEN, KW .
JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (11) :1771-1778
[8]   PREDICTION OF RELAPSE OR SURVIVAL IN PATIENTS WITH NODE-NEGATIVE BREAST-CANCER BY DNA FLOW-CYTOMETRY [J].
CLARK, GM ;
DRESSLER, LG ;
OWENS, MA ;
POUNDS, G ;
OLDAKER, T ;
MCGUIRE, WL .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (10) :627-633
[9]   PROTOONCOGENE ABNORMALITIES IN HUMAN-BREAST CANCER - CORRELATIONS WITH ANATOMIC FEATURES AND CLINICAL COURSE OF DISEASE [J].
CLINE, MJ ;
BATTIFORA, H ;
YOKOTA, J .
JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (07) :999-1006
[10]   BREAST-CANCER THERAPY - EXERCISING ALL OUR OPTIONS [J].
DEVITA, VT .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (08) :527-529